Osteoporose - DVO Leitlinien - Dr. Friederike Thomasius (Frankfurt am Main)

Dr. Friederike Thomasius erläutert Diagnostik und Therapie der Osteoporose, fokussierend auf DVO Leitlinie Osteoporose 2023 2023 DVO Leitlinien Osteoporose, die unter Koordination und Vorsitz von Dr. Thomasius erstellt wurde. Dr. Thomasius ist Präsidentin der Deutschen Gesellschaft für Osteologie. Das Gespräch wurde am 28. 4.2025 geführt. Moderatoren: Prof. Dr. Markus Ketteler (Stuttgart), Priv.-Doz. Dr. Insa Emrich (Homburg), Frau Carolin Schneppe (Frankfurt am Main) und Prof. Dr. Gunnar Heine (Frankfurt am Main).Weitere Literatur: Clinical Practice Guideline: The Diagnosis and Treatment of Osteoporosis. Thomasius F, Kurth A, Baum E, Drey M, Maus U, Schmidmaier R. Dtsch Arztebl Int 2025 doi: 10.3238/arztebl.m2024.0222 KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. Kidney Int Suppl 2017 doi: 10.1016/j.kisu.2017.04.001 Association of Glucagon-like peptide-1 receptor agonists use with fracture risk in type 2 diabetes: A meta-analysis of randomized controlled trials. Zhang Y, Chen G, Wang W, Yang D, Zhu D, Jing Y. Bone 2025 doi: 10.1016/j.bone.2024.117338 Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G; Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 2006 doi: 10.1038/sj.ki.5000414 Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Ketteler M, Evenepoel P, Holden RM, Isakova T, Jørgensen HS, Komaba H, Nickolas TL, Sinha S, Vervloet MG, Cheung M, King JM, Grams ME, Jadoul M, Moysés RMA; Conference Participants Kidney Int 2025 doi: 10.1016/j.kint.2024.11.013 An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD. Monnerat S, Refardt J, Potasso L, Meier C, Christ-Crain M J Clin Endocrinol Metab 2023 doi: 10.1210/clinem/dgad238 Effect of hyponatremia normalization on osteoblast function in patients with SIAD. Potasso L, Refardt J, Meier C, Christ-Crain M Eur J Endocrinol 2021 doi: 10.1530/EJE-21-0604 Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent Patients. Bird ST, Smith ER, Gelperin K, Jung TH, Thompson A, Kambhampati R, Lyu H, Zhao H, Zhao Y, Zhu Y, Easley O, Niak A, Wernecke M, Chillarige Y, Zemskova M, Kelman JA, Graham DJ JAMA 2024 doi: 10.1001/jama.2023.28239